3.3450
+0.2450
+(7.90%)
At close: April 15 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 8.04M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Indirect | -- | Feb 17, 2025 |
| Rothwell (Alexander John) Senior Officer of Issuer | -- | Direct | -- | Feb 17, 2025 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Direct | -- | Oct 31, 2024 |
| Freedman (Joseph Stuart) Director of Issuer | -- | Indirect | -- | Oct 31, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.61 per share. | Direct | 1,044 | Sep 10, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.73 per share. | Direct | 4,095 | Sep 4, 2024 |
| Montalbano (John S.) Director of Issuer | Acquisition or disposition in the public market at price 2.56 per share. | Direct | 37,873 | Jun 28, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.66 per share. | Direct | 2,926 | Jun 17, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.81 per share. | Direct | 2,248 | Jun 11, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 2.73 per share. | Direct | 2,730 | Jun 7, 2024 |
| Wilmink (Michael) Director of Issuer | Acquisition or disposition in the public market at price 3.00 per share. | Direct | 1,920 | May 10, 2024 |
Related Tickers
MSCLF Satellos Bioscience Inc.
0.4500
0.00%
MSCL.TO Satellos Bioscience Inc.
0.6500
-2.99%
MDNAF Medicenna Therapeutics Corp.
0.7100
-0.01%
FENC Fennec Pharmaceuticals Inc.
5.25
-0.38%
KNTPF Kintor Pharmaceutical Limited
0.1774
0.00%
GNFTF Genfit S.A.
3.5400
0.00%
MLLCF Molecular Partners AG
4.2200
0.00%
SER Serina Therapeutics, Inc.
5.10
-4.10%
OTLC Oncotelic Therapeutics, Inc.
0.0500
-13.64%
ACHFF Arch Biopartners Inc.
1.3700
+2.24%